Ubisoft Stock Climbs 3.28% to €5.04 Nine Days Before Annual Results
The stock of the French video game publisher picks up speed at midday, in a Parisian market that is otherwise trending downwards. The CAC 40 is down 0.92% at 8,037.69 points during the session, and the SBF 120 loses 0.82%. Nine days before the announcement of the 2025-2026 annual results, the stock is regaining some color.
Fourth Largest Increase in the SBF 120 at Mid-Session
Ubisoft's stock is up 3.28% at €5.04 at midday. The stock is among the top five gains in the SBF 120, trailing behind Valneva (+11.21%), Nanobiotix (+10.62%), and Teleperformance (+5.76%). This session goes against the trend of a broader index that is down 0.82%. The movement occurs in a context of persistent selling pressure. According to AMF/ESMA statements published on May 6, 2026, the cumulative net short position on the stock reaches 14.70% of the capital, declared by ten funds including Citadel Advisors (3.52%), Marshall Wace (2.28%), and D.E. Shaw (1.88%). This level has varied little over a month (+0.03 point). Recently, the stock has gained 2.02% over the week and 8.17% over three months. The performance over one year remains heavily negative, at -54.78%.
Price Above Short-Term Averages, Annual Publication on May 20
The price is at €5.04, above the MM20 (€4.83) and significantly above the MM50 (€4.34, a gap of 16.18%). The price is €5.04, which is 23.26% below the MM200 (€6.57), indicating a fundamental decline in the stock over twelve months. The RSI at 56 remains neutral, without directional excess. The upper Bollinger band at €5.43 provides a technical reference above the current price. In product news, Ubisoft announced on May 7 the release of Assassin's Creed Black Flag Resynced on July 9 on PS5, Xbox Series X|S, and PC, and unveiled year 3 of Skull and Bones structured into four seasons. The next appointment is the publication of the revenue and results for the fiscal year 2025-2026, expected on May 20, 2026.
